雙肺多發結節伴囊腔影_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

姚秀娟 , 李蘭鳳 , 洪如鈞 , 何毅輝 ,  謝寶松

福建省立醫院福建醫科大學省立臨床醫學院（福建福州 ?350001）;

Corresponding?author：

謝寶松, Email: xbaosong@126.com

Keywords：

DOI：

10.7507/1671-6205.202101036

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 姚秀娟, 李蘭鳳, 洪如鈞, 何毅輝, 謝寶松. 雙肺多發結節伴囊腔影. Chinese Journal of Respiratory and Critical Care Medicine, 2021, 20(11): 817-820. doi: 10.7507/1671-6205.202101036 Copy

1.	Suri HS, Yi ES, Nowakowski GS, et al. Pulmonary langerhans cell histiocytosis. Orphanet J Rare Dis, 2012, 7: 16.
2.	Mourah S, How-Kit A, Meignin V, et al. Recurrent NRAS mutations in pulmonary langerhans cell histiocytosis. Eur Respir J, 2016, 47(6): 1785-1796.
3.	Rodriguez-Galindo C, Allen CE. Langerhans cell histiocytosis. Blood, 2020, 135(16): 1319-1331.
4.	Allen CE, Merad M, McClain KL. Langerhans-cell histiocytosis. N Engl J Med, 2018, 379(9): 856-868.
5.	Goyal G, Young JR, Koster MJ, et al. The Mayo clinic histiocytosis working group consensus statement for the diagnosis and evaluation of adult patients with histiocytic neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman Disease. Mayo Clin Proc, 2019, 94(10): 2054-2071.
6.	Kumar A, Cherian SV, Vassallo R, et al. Current concepts in pathogenesis, diagnosis, and management of smoking-related interstitial lung diseases. Chest, 2018, 154(2): 394-408.
7.	Lorillon G, Tazi A. How I manage pulmonary langerhans cell histiocytosis. Eur Respir Rev, 2017, 26(145): 170070.
8.	許秦風, 郭萬華. 肺朗格漢斯細胞組織細胞增生癥的高分辨率CT及¹⁸F-FDG PET/CT表現. 中國醫學影像學雜志, 2016, 24(10): 741-745.
9.	Obert J, Vercellino L, Van Der Gucht A, et al. ¹⁸F-fluorodeoxyglucose positron emission tomography-computed tomography in the management of adult multisystem Langerhans cell histiocytosis. Eur J Nucl Med Mol Imaging, 2017, 44(4): 598-610.
10.	Hazim AZ, Ruan GJ, Ravindran A, et al. Efficacy of BRAF-inhibitor therapy in BRAF^V600E-mutated adult Langerhans cell histiocytosis. Oncologist, 2020, 25(12): 1001-1004.

1. Suri HS, Yi ES, Nowakowski GS, et al. Pulmonary langerhans cell histiocytosis. Orphanet J Rare Dis, 2012, 7: 16.
2. Mourah S, How-Kit A, Meignin V, et al. Recurrent NRAS mutations in pulmonary langerhans cell histiocytosis. Eur Respir J, 2016, 47(6): 1785-1796.
3. Rodriguez-Galindo C, Allen CE. Langerhans cell histiocytosis. Blood, 2020, 135(16): 1319-1331.
4. Allen CE, Merad M, McClain KL. Langerhans-cell histiocytosis. N Engl J Med, 2018, 379(9): 856-868.
5. Goyal G, Young JR, Koster MJ, et al. The Mayo clinic histiocytosis working group consensus statement for the diagnosis and evaluation of adult patients with histiocytic neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman Disease. Mayo Clin Proc, 2019, 94(10): 2054-2071.
6. Kumar A, Cherian SV, Vassallo R, et al. Current concepts in pathogenesis, diagnosis, and management of smoking-related interstitial lung diseases. Chest, 2018, 154(2): 394-408.
7. Lorillon G, Tazi A. How I manage pulmonary langerhans cell histiocytosis. Eur Respir Rev, 2017, 26(145): 170070.
8. 許秦風, 郭萬華. 肺朗格漢斯細胞組織細胞增生癥的高分辨率CT及¹⁸F-FDG PET/CT表現. 中國醫學影像學雜志, 2016, 24(10): 741-745.
9. Obert J, Vercellino L, Van Der Gucht A, et al. ¹⁸F-fluorodeoxyglucose positron emission tomography-computed tomography in the management of adult multisystem Langerhans cell histiocytosis. Eur J Nucl Med Mol Imaging, 2017, 44(4): 598-610.
10. Hazim AZ, Ruan GJ, Ravindran A, et al. Efficacy of BRAF-inhibitor therapy in BRAF^V600E-mutated adult Langerhans cell histiocytosis. Oncologist, 2020, 25(12): 1001-1004.

Previous Article
肺梗死樣梭形細胞癌一例并文獻復習
Next Article
靶肺去神經療法在慢性阻塞性肺疾病中的應用進展

Chinese Journal of Respiratory and Critical Care Medicine

雙肺多發結節伴囊腔影

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content